Q2 EPS Estimate for Denali Therapeutics Increased by Analyst
Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) – Zacks Research increased their Q2 2025 earnings per share (EPS) estimates for Denali Therapeutics in a note issued to investors on Tuesday, May 27th. Zacks Research analyst A. Chakraborty now forecasts that the company will post earnings per share of ($0.77) for the quarter, up from their […]
Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) – Zacks Research increased their Q2 2025 earnings per share (EPS) estimates for Denali Therapeutics in a note issued to investors on Tuesday, May 27th. Zacks Research analyst A. Chakraborty now forecasts that the company will post earnings per share of ($0.77) for the quarter, up from their […]
